Quarterly report · Q2
6951.TEDINET S100PKJL
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥64.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥138.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥53.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥6.9bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.6bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.8bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥3.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥189.8bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥189.6bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥168.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥97.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥103.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥92.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥85.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥77.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥39.3bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥44.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥42.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥22.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥648m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥438m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥141.67 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥246.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.59 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥2.6bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥9.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥8.5bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥8.5bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥270m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.8bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥35.8bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥81m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥64.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥64.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥9.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.8bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥820m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥29.5bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | −¥670m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥53.4bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥6.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 553
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | Prior1YTDDuration | 53368000000 | JPY |
| Net sales | CurrentYTDDuration | 64743000000 | JPY |
| Cost of sales | Prior1YTDDuration | 30540000000 | JPY |
| Cost of sales | CurrentYTDDuration | 35550000000 | JPY |
| Gross profit | Prior1YTDDuration | 22828000000 | JPY |
| Gross profit | CurrentYTDDuration | 29193000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 4126000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 4511000000 | JPY |
| Other sga | Prior1YTDDuration | 15025000000 | JPY |
| Other sga | CurrentYTDDuration | 17772000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 19151000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 22283000000 | JPY |
| Operating income | Prior1YTDDuration | 3676000000 | JPY |
| Operating income | CurrentYTDDuration | 6909000000 | JPY |
| Interest income noi | Prior1YTDDuration | 12000000 | JPY |
| Interest income noi | CurrentYTDDuration | 16000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 90000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 91000000 | JPY |
| Revenue from acceptance of development services noi | Prior1YTDDuration | 24000000 | JPY |
| Revenue from acceptance of development services noi | CurrentYTDDuration | 44000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 1546000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | 270000000 | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 175000000 | JPY |
| Subsidy income noi | Prior1YTDDuration | 712000000 | JPY |
| Subsidy income noi | CurrentYTDDuration | － | JPY |
| Other noi | Prior1YTDDuration | 129000000 | JPY |
| Other noi | CurrentYTDDuration | 195000000 | JPY |
| Non operating income | Prior1YTDDuration | 1239000000 | JPY |
| Non operating income | CurrentYTDDuration | 2069000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 81000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 38000000 | JPY |
| Loss on sales of accounts receivable noe | Prior1YTDDuration | 3000000 | JPY |
| Loss on sales of accounts receivable noe | CurrentYTDDuration | 4000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | 20000000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | － | JPY |
| Other noe | Prior1YTDDuration | 61000000 | JPY |
| Other noe | CurrentYTDDuration | 87000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 167000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 130000000 | JPY |
| Ordinary income | Prior1YTDDuration | 4749000000 | JPY |
| Ordinary income | CurrentYTDDuration | 8848000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 21000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 4000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | － | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 818000000 | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | Prior1YTDDuration | － | JPY |
| Gain on sales of subsidiaries and affiliates stocks ei | CurrentYTDDuration | 156000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 21000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 978000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |